The authors concluded that GLP-1 receptor agonists are a safe and effective adjunct treatment for weight reduction in women with PCOS. A 2025 review of human and animal studies concluded that GLP-1 receptor agonists offer a multifaceted approach to PCOS management, with benefits across both metabolic and reproductive domains, including improvements in insulin sensitivity, weight loss, and menstrual regularity, with emerging evidence suggesting possible effects on gut microbiota composition
Both patterns appear in the research framing
Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury
Contact your healthcare provider after you give yourself the injection to tell them
Proceedings of the Educational Seminar, Washington DC, Health Industries Manufacturers Association, pp
Skin damage, however, is also a problem